|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of goods sold | ||||
| Gross profit | ||||
| Selling, general and administrative expenses | ||||
| Impairment loss | ||||
| Gain on sale of asset | ||||
| Loss from operations | ||||
| Other income (expenses) | ||||
| Interest expense, net | ||||
| Total other income / (expense) | ||||
| Loss from extinguishment of debt | ||||
| Gain on change in derivative liability | ||||
| Other income / (loss) | ||||
| Total other income (expenses) | ||||
| NET LOSS | ||||
| Deemed dividend on warrants | ||||
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | ||||
| Net Income / (Loss) per common share - basic and diluted (1) | ||||
| Weighted-Average Number of Common Shares Outstanding - Basic and Diluted (1) |
Loading...
